Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.14 CAD
−69.11 M CAD
0.00 CAD
16.19 M
About Aptose Biosciences, Inc.
Sector
CEO
William G. Rice
Headquarters
Toronto
Website
Founded
1986
FIGI
BBG000FYQ6V2
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
Aptos Biosciences APTO - Testing critical supportThis level should provide substantial support for a possible bounce. The risk/reward here is favorable for a long. Stop loss is essential, as always.
APTO Technical Analysis 🧙Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm
APTO Technical Analysis 🧙Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm
APTO Technical Analysis. 🧙Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of APS is 0.54 CAD — it hasn't changed in the past 24 hours. Watch APTOSE BIOSCIENCES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange APTOSE BIOSCIENCES INC stocks are traded under the ticker APS.
APS stock has risen by 3.85% compared to the previous week, the month change is a 10.20% rise, over the last year APTOSE BIOSCIENCES INC has showed a −87.29% decrease.
APS stock is 3.70% volatile and has beta coefficient of 1.03. Track APTOSE BIOSCIENCES INC stock price on the chart and check out the list of the most volatile stocks — is APTOSE BIOSCIENCES INC there?
Today APTOSE BIOSCIENCES INC has the market capitalization of 10.54 M, it has increased by 1.85% over the last week.
Yes, you can track APTOSE BIOSCIENCES INC financials in yearly and quarterly reports right on TradingView.
APTOSE BIOSCIENCES INC is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
APS earnings for the last quarter are −0.50 CAD per share, whereas the estimation was −0.87 CAD resulting in a 42.19% surprise. The estimated earnings for the next quarter are −0.96 CAD per share. See more details about APTOSE BIOSCIENCES INC earnings.
APS net income for the last quarter is −9.48 M CAD, while the quarter before that showed −9.92 M CAD of net income which accounts for 4.42% change. Track more APTOSE BIOSCIENCES INC financial stats to get the full picture.
No, APS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 35.00 employees. See our rating of the largest employees — is APTOSE BIOSCIENCES INC on this list?
Like other stocks, APS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APTOSE BIOSCIENCES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So APTOSE BIOSCIENCES INC technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating APTOSE BIOSCIENCES INC stock shows the sell signal. See more of APTOSE BIOSCIENCES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.